GGrantIndex
← Search

DEVELOPMENT OF ORALLY BIOAVAILABLE THERAPEUTICS BY THE CHLOROPLAST EXPRESSION SYSTEM TO COUNTER MUSCLE DEGENERATION, WEAKNESS, AND FIBROSIS IN DMD

$504,738FY2014Department of the ArmyDOD

Trustees Of The University Of Pennsylvania, The

Investigators

View source on USAspending →
DEVELOPMENT OF ORALLY BIOAVAILABLE THERAPEUTICS BY THE CHLOROPLAST EXPRESSION SYSTEM TO COUNTER MUSCLE DEGENERATION, WEAKNESS, AND FIBROSIS IN DMD · GrantIndex